Quantcast

Latest Biomarkers Stories

2014-08-27 23:08:41

Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with privately held Australian biomarker research company, Minomic International Limited, to develop MIL-38, an antibody drug conjugate (ADC) for prostate cancer therapy. Under the agreement, Catalent will initially produce the antibody for a clinical study with a view to larger scale production subject...

2014-08-26 12:26:17

LONDON, Aug. 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biomarkers: Technologies and Global Marketshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/biomarkers/biomarkers_technologies_global_markets.htmlREPORT HIGHLIGHTSThe global biomarkers market is expected to grow from $29.3 billion in 2013 to $53.6 billion in 2018, a compound annual growth rate (CAGR) of 12.8%.This report provides:An overview of the global market for...

2014-08-08 23:05:04

Biomarkers are substances produced by the body that can help assess disease risk. Boston, MA (PRWEB) August 08, 2014 Wouldn't it be wonderful if a single blood test could gauge the heart's health? Medicine isn't quite yet at that point. But there are a few indicators that can signal where your cardiovascular health is headed and let you know whether you need to take action now to prevent a heart attack or stroke, according to the August 2014 Harvard Women's Health Watch....

2014-08-01 16:23:54

Plasma RNA biomarker panel for colorectal cancer screening JERUSALEM, Aug. 1, 2014 /PRNewswire-iReach/ -- Bio-MarCare Technologies, a leader in the development of plasma RNA biomarkers for colorectal cancer (CRC), is offering for sale its proprietary Colon-MarCarePlex(TM) technology for the pre-cancerous polyps screening in blood. The purchaser will receive all intellectual property (IP) rights, know-how and current business relationships associated with MarCarePlex(TM) technology....

google baseline study
2014-07-26 04:48:02

redOrbit Staff & Wire Reports - Your Universe Online Having already waded knee-deep into the world of driverless cars, optical head-mounted displays and other wearable technology, Google is reportedly poised to tackle its biggest challenge yet – a perfectly healthy human body. According to Alistair Barr of The Wall Street Journal, the Mountain View, California-based firm’s Baseline Study project will collect anonymous genetic and molecular information from 175 men and women in...

2014-07-24 16:26:56

HILDEN, Germany, and MARSEILLE, France, July 24, 2014 /PRNewswire/ -- - Exclusive global license from University of Tokyo enables development of QIAGEN assays for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, for blood cancers - Mutations of SF3B1 gene, to be targeted by new test, indicate favorable prognosis for patients with bone marrow disorders known as myelodysplastic syndromes - QIAGEN...

2014-07-24 16:26:25

RALEIGH-DURHAM, N.C., July 24, 2014 /PRNewswire/ -- LSI Medience Corporation today announced that the company has signed an Agreement with Kineticos, a Raleigh-Durham, NC based life sciences consulting company. Kineticos will support LSI Medience in identifying opportunities for Presepsin, a new biomarker in sepsis management, to demonstrate utility in clinical trials. The Presepsin biomarker testing product has shown potential utility in diagnosis of sepsis, prognosis of septic...

2014-07-23 08:27:25

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cardiac Biomarkers: Technologies and Global Marketshttps://www.reportbuyer.com/product/2070047/Cardiac-Biomarkers-Technologies-and-Global-Markets.html REPORT HIGHLIGHTSThe global market for in vitro diagnostic tests for cardiac biomarkers was estimated at $3.1 billion in 2012 and nearly $4 billion in 2013. This market is predicted to reach $7.2 billion by 2018, at a compound annual growth...

2014-07-15 23:00:16

Researchers at the Western Connecticut Health Network Biomedical Research Institute use a multidisciplinary integrated approach to discover possible predictive biomarkers of tumor behavior for people with colon cancer. Danbury, Connecticut (PRWEB) July 16, 2014 The goal of finding effective treatments for people with colorectal cancer based on their unique molecular characteristics is still elusive. Researchers from the Western Connecticut Health Network Biomedical Research Institute have...

2014-07-07 09:48:40

University of Texas M. D. Anderson Cancer Center Alas, the thankless pseudogene. Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism's survival and are the "last stop" for removal of genomic waste. Not any more. The pseudogene's day may have arrived thanks to scientists at The University of Texas MD Anderson Cancer Center in Houston. Han Liang, Ph.D.,...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related